Latest Tenofovir Stories
The HIV/AIDS epidemic often has a woman's face because the proportion of women infected with HIV has been on the rise for a decade.
New research from the Centers for Disease Control and Prevention suggests that the HIV drug teneofovir can also prevent the contraction of the virus for intravenous drug users.
A reformulated version of an anti-HIV gel developed for vaginal use was found safe and acceptable by HIV-negative men and women who used it rectally.
Replacing brand-name drugs recommended for control of HIV infection with generic medications could save nearly $1 billion a year on health care costs in the US.
A joint effort by the University of Utah and CONRAD has resulted in the development of an intravaginal ring that can be utilized by women to stop the transmission of HIV through sex.
The FDA recently approved the sale and distribution of Stribild, an HIV medication that includes four different drugs in one pill. The FDA believes that Stribild offers complete treatment for infections related to HIV.
- A political dynamiter.